NCT03556215

Brief Summary

The prevalence of Eustachian tube (ET) dysfunction in adults reaches 1%. It causes a feeling of fullness in the ear, otalgia and hearing loss and can lead to recurrent acute otitis media, development of chronic otitis media with effusion and cholesteatoma. Endoscopic transnasal balloon ET dilatation is a novel surgical technique for ET dysfunction. The main goal is to restore ET function by dilation its cartilaginous part leading to better ventilation and drainage of the middle ear. However, its real effect in the treatment of particular subgroups of patients with ET dysfunction remains unknown. Patients are mostly evaluated as one group. Adults with chronic ET dysfunction will be strictly divided into particular subgroups and included in the study. Subgroups will be compared in order to identify treatment effect in particular subgroups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2016

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

May 20, 2018

Completed
25 days until next milestone

First Posted

Study publicly available on registry

June 14, 2018

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2020

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2020

Completed
Last Updated

December 7, 2022

Status Verified

December 1, 2022

Enrollment Period

4.1 years

First QC Date

May 20, 2018

Last Update Submit

December 6, 2022

Conditions

Keywords

otitis media with effusionballoon tuboplastyEustachian tubeEustachian tube dysfunction

Outcome Measures

Primary Outcomes (1)

  • Otomicro(endo)scopy

    Otomicro(endo)scopy will be used to assess the presence or absence of effusion.

    36 months

Secondary Outcomes (6)

  • Symptoms severity according to Visual Analogue Scale

    36 months

  • ETDQ-7 questionnaire

    36 months

  • Tympanometry

    36 months

  • Audiometry

    36 months

  • Tubomanometry

    36 months

  • +1 more secondary outcomes

Study Arms (3)

Effusion, Eustachian tube dilatation device and myringotomy

EXPERIMENTAL

Patients with chronic Eustachian tube dysfunction and recurrence of chronic otitis media with effusion after tympanostomy tube exclusion, intervention: balloon Eustachian tuboplasty, and myringotomy

Device: Eustachian tube dilatation deviceProcedure: Myringotomy

Effusion, Eustachian tube dilatation device

EXPERIMENTAL

Patients with chronic Eustachian tube dysfunction and recurrence of chronic otitis media with effusion after tympanostomy tube exclusion, intervention: balloon Eustachian tuboplasty only (no myringotomy)

Device: Eustachian tube dilatation device

No effusion, Eustachian tube dilatation device

EXPERIMENTAL

Patients with chronic Eustachian tube dysfunction and airy middle ear (without otitis media with effusion), Eustachian tube dilatation device, no myringotomy

Device: Eustachian tube dilatation device

Interventions

Balloon Eustachian tuboplasty will be performed using a Eustachian tube dilatation device.

Effusion, Eustachian tube dilatation deviceEffusion, Eustachian tube dilatation device and myringotomyNo effusion, Eustachian tube dilatation device
MyringotomyPROCEDURE

Myringotomy will be performed using a standard procedure.

Effusion, Eustachian tube dilatation device and myringotomy

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • adult patients with chronic Eustachian tube dysfunction lasting more than 6 months, with or without recurrence of chronic otitis media with effusion after tympanostomy

You may not qualify if:

  • anatomic obstruction in nasopharynx
  • nasopharyngeal cancer
  • head and neck cancer
  • other middle ear surgery except for myringotomy or tympanostomy
  • chronic suppurative otitis media
  • patients who could not undergo general anesthesia
  • patients who did not give consent to be included in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University Hospital Hradec Králové

Hradec Králové, Hradec Králové Region, 500 05, Czechia

Location

University Hospital Ostrava

Ostrava, Moravian-Silesian Region, 708 52, Czechia

Location

Related Publications (1)

  • Swords C, Smith ME, Patel A, Norman G, Llewellyn A, Tysome JR. Balloon dilatation of the Eustachian tube for obstructive Eustachian tube dysfunction in adults. Cochrane Database Syst Rev. 2025 Feb 26;2(2):CD013429. doi: 10.1002/14651858.CD013429.pub2.

MeSH Terms

Conditions

Otitis Media with Effusion

Interventions

Middle Ear Ventilation

Condition Hierarchy (Ancestors)

Otitis MediaOtitisEar DiseasesOtorhinolaryngologic Diseases

Intervention Hierarchy (Ancestors)

OstomySurgical Procedures, OperativeOtologic Surgical ProceduresOtorhinolaryngologic Surgical Procedures

Study Officials

  • Pavel Komínek, prof.,MD,Ph.D.,MBA

    University Hospital Ostrava

    STUDY CHAIR
  • Martin Formánek, MD

    University Hospital Ostrava

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
No masking was used in the study
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Interventional parallel randomized controlled prospective trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 20, 2018

First Posted

June 14, 2018

Study Start

May 1, 2016

Primary Completion

May 31, 2020

Study Completion

November 30, 2020

Last Updated

December 7, 2022

Record last verified: 2022-12

Locations